USPTO patent application for bioprocess on cell cultures

ChangeBridge: Patent Apps - Biotech (C12N)

Detected March 27th, 2026

Summary

The USPTO has published a patent application (US20260085266A1) detailing a method for performing a bioprocess on liquid immune or naive cell cultures. The application, filed on December 13, 2022, describes an integrated bioprocessing system with preconfigurable cartridges for cell therapy.

View original document View source feed page

What changed

This document is a USPTO patent application (US20260085266A1) for a method of performing a bioprocess on cell cultures intended for autologous or allogenic cell therapy. The described system involves an integrated bioprocessing unit with standardized interfaces between a base structure and preconfigurable cartridges, allowing for multiple processing steps within different cartridges using the same base structure interface.

As this is a patent application, it does not impose immediate regulatory obligations. However, companies in the biotechnology and pharmaceutical sectors involved in cell therapy development should review this application for potential intellectual property considerations and to understand emerging technologies in bioprocessing. The application was filed on December 13, 2022, and published with an application number of 19114269.

Source document (simplified)

← USPTO Patent Applications

METHOD FOR PERFORMING A BIOPROCESS ON LIQUID IMMUNE OR NAIVE CELL CULTURES TO OBTAIN PROCESSED CELL CULTURES

Application US20260085266A1 Kind: A1 Mar 26, 2026

Inventors

Adrian Stacey, Fanny Prouté

Abstract

Method for performing a bioprocess to obtain processed cell cultures, wherein the processed cell cultures are destined for autologous or allogenic cell therapy, wherein the bioprocess is performed on an integrated bioprocessing system, wherein the bioprocess comprises a sequence of processing steps, wherein the processing steps each comprise at least one operation, wherein the bioprocess system comprises a base structure and preconfigurable cartridges, wherein the bioprocess system performs operations of the bioprocess via an interaction of the base structure with the cartridges, wherein the cartridges and the base structure comprise matching standardized interfaces for an interaction of the base structure with the respective cartridge, wherein the bioprocess system performs at least two operations of the bioprocess inside at least two differently preconfigured cartridges by an interaction of the base structure with the cartridges via the same base structure interface and/or identical base structure interfaces and matching cartridge interfaces.